Hermes Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$698K Sell
6,450
-363
-5% -$39.5K 0.01% 194
2018
Q1
$721K Buy
6,813
+363
+6% +$42.2K 0.01% 192
2017
Q4
$756K Buy
6,450
+1,163
+22% +$132K 0.01% 192
2017
Q3
$601K Buy
5,287
+382
+8% +$44.1K 0.01% 189
2017
Q2
$611K Buy
+4,905
New +$582K 0.01% 181
2017
Q1
Sell
-4,905
Closed -$491K 226
2016
Q4
$491K Hold
4,905
0.01% 193
2016
Q3
$619K Hold
4,905
0.01% 186
2016
Q2
$573K Hold
4,905
0.01% 185
2016
Q1
$511K Hold
4,905
0.01% 189
2015
Q4
$489K Hold
4,905
0.01% 192
2015
Q3
$447K Hold
4,905
0.01% 189
2015
Q2
$520K Hold
4,905
0.01% 188
2015
Q1
$560K Hold
4,905
0.01% 184
2014
Q4
$540K Hold
4,905
0.01% 183
2014
Q3
$479K Hold
4,905
0.01% 186
2014
Q2
$495K Hold
4,905
0.01% 198
2014
Q1
$450K Buy
4,905
+991
+25% +$91.3K 0.01% 205
2013
Q4
$354K Hold
3,914
0.01% 218
2013
Q3
$312K Hold
3,914
0.01% 208
2013
Q2
$285K Buy
+3,914
New +$293K 0.01% 224

Other funds holding ZBH

Hermes Investment Management's ZBH Position: Q2 2018 in Review

Hermes Investment Management reduced its Zimmer Biomet (ZBH) stake by 5.3% in Q2 2018, selling an estimated $39.5K and leaving 6,450 shares worth $698K. The position accounts for 0.01% of the portfolio, ranked #194.

Hermes Investment Management first reported a position in ZBH in Q2 2013 and has held it in 20 quarters since. The position peaked at $756K in Q4 2017. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

  • Hermes Investment Management held 6,450 shares of Zimmer Biomet worth $698K as of Q2 2018.
  • Hermes Investment Management sold 363 Zimmer Biomet shares in Q2 2018, an estimated $39.5K.
  • Zimmer Biomet made up 0.01% of Hermes Investment Management's portfolio in Q2 2018, its #194 holding.
  • Hermes Investment Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 20 quarters since.
  • Hermes Investment Management's Zimmer Biomet position peaked at $756K in Q4 2017.
  • 869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Hermes Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.